• A GH Secretagogue Receptor Agonist (LUM-201) Elicits Greater GH Responses than Standard GH Secretagogues in Subjects of a Pediatric GH Deficiency Trial
• A novel cause for primordial dwarfism revealed: defective tRNA modification
• A novel CLCNKB mutation in a Chinese girl with classic Bartter syndrome: a case report
• A prospective study revealing the role of an immune-related eRNA, WAKMAR2, in breast cancer
• Adding T2-Weighted Images to FAST1 Protocol to Evaluate the Anatomy of the Hypothalamic-Pituitary Region
• Adult height after treatment of neurosecretory dysfunction and comparison to idiopathic GHD
• An open-label extension of a phase 2 dose-finding study of once-weekly somatrogon vs. once-daily Genotropin in children with short stature due to growth hormone deficiency: results following 5 years of treatment
• Association of Daily Growth Hormone Injection Adherence and Height Among Children With Growth Hormone Deficiency
• Benefits and risks evaluation of recombinant human growth hormone replacement therapy in children with GHD after craniopharyngioma surgery
• Cardiac functions in children with growth hormone deficiency: Effects of one year of GH replacement therapy
• Changes, limitations, and prospects of adult height in GH treatment for Japanese GHD patients
• Characteristics of paediatric hypopituitarism patients in Latvia: a single-centre 25-year retrospective study
• Clinical considerations on a case of primordial progeric nanism
• Clinical profile of Laron dwarfism - experience from a tertiary care institute in Chennai
• COMPARISON OF BONE MATURATION RESPONSE TO TREATMENT WITH SHORT AND LONG-TERM GROWTH HORMONE THERAPY IN SHORT-STATURE PEDIATRIC PATIENTS
• Comparison of two prediction models in a clinical setting to predict growth in prepubertal children on recombinant growth hormone
• Curve matching to predict growth in patients receiving growth hormone therapy: An interpretable & explainable method
• Cushing disease due to a somatic <em>USP8</em> mutation in a patient with evolving pituitary hormone deficiencies due to a germline <em>GH1</em> splicing variant
• Decreased lifespan in female "Munchkin" actors from the cast of the 1939 film version of The Wizard of Oz does not support the hypothesis linking hypopituitary dwarfism to longevity
• Demographic characteristics of children with growth hormone deficiency from 1996 to 2015 in Japan: 20 years of data from the foundation for growth science in Japan
• Dental arches in inherited severe isolated growth hormone deficiency
• Diagnosis of GH Deficiency Without GH Stimulation Tests
• Diagnosis of Growth Hormone Deficiency Remains a Judgment Call - and That Is Good
• Different Cases of Short Stature
• Dilated cardiomyopathy in a cat with congenital hyposomatotropism
• Dose-exposure-IGF-I response of once-weekly somapacitan in adults with GH deficiency
• Effect of different doses of recombinant human growth hormone therapy on children with growth hormone deficiency: a retrospective observational study
• Effective GH Replacement With Once-weekly Somapacitan vs Daily GH in Children with GHD: 3-year Results From REAL 3
• Effectiveness, economical and safety aspects of growth hormone (GH) therapy in growth promoting doses in patients with isolated GH deficiency after the attainment of near-final height. Is there a need to modify the criteria of therapy withdrawal?
• Effects of adult growth hormone deficiency and replacement therapy on the cardiometabolic risk profile
• Efficacy and Safety of Once-Weekly Somatrogon Compared with Once-Daily Somatropin (Genotropin®) in Japanese Children with Pediatric Growth Hormone Deficiency: Results from a Randomized Phase 3 Study
• Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study
• Efficacy, safety, quality of life, adherence and cost-effectiveness of long-acting growth hormone replacement therapy compared to daily growth hormone in children with growth hormone deficiency: A systematic review and meta-analysis
• Endocrine Abnormalities and Growth Characterization in Colombian Pediatric Patients with 22q11 Deletion Syndrome
• Endocrine disorders in patients with transfusion-dependent hereditary anemias
• Evaluation of efficacy and safety of long-acting PEGylated recombinant human growth hormone (Jintrolong) for patients with growth hormone deficiency
• Function and form of the shoulder in congenital and untreated growth hormone deficiency
• Gender-specific soluble α-klotho levels as marker of GH deficiency in children: a case-control study
• Growth hormone (GH) deficiency and GH replacement therapy in patients previously treated for Cushing's disease
• Growth hormone deficit. Does the first year of treatment influence adult height?
• Growth hormone responses during arginine and clonidine stimulation test: Correlations with patients' auxological and metabolic parameters in a single centre study
• Growth of teeth and bones in adult subjects with congenital untreated isolated growth hormone deficiency
• Growth Responses During 3 Years of Growth Hormone Treatment in Children and Adolescents With Growth Hormone Deficiency: Comparison Between Idiopathic, Organic and Isolated Growth Hormone Deficiency, and Multiple Pituitary Hormone Deficiency
• High-Performance Liquid Chromatography-Mass Spectrometry-based Metabolic Profiling of Adult Growth Hormone Deficiency
• History of GH treatment in Japan
• IGF-1/IGFBP-3 Serum Ratio as a Robust Measure to Determine GH Deficiency and Guide Human Recombinant GH Therapy
• Improved impedance to maladaptation and enhanced VCAM-1 upregulation with resistance-type training in the long-lived Snell dwarf (<em>Pit1^dw/dw</em>) mouse
• Inside the Noonan "universe": Literature review on growth, GH/IGF axis and rhGH treatment: Facts and concerns
• Investigating significant health trends in growth hormone treatments registry: rationale, aims and design of a nationwide prospective registry (study protocol)
• Isolated childhood growth hormone deficiency: a 30-year experience on final height and a new prediction model
• Isolated growth hormone deficiency and amenorrhea - Case report
• Isolated growth hormone deficiency in children with vertically transmitted short stature: What do the genes tell us?
• Isolated growth hormone deficiency type IA due to a novel GH1 variant: a case report
• Letter to the Editor From Chatelain et al: "Weekly Somapacitan Is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial"
• Long-term Pegylated GH for Children With GH Deficiency: A Large, Prospective, Real-world Study
• Long-term Safety of Growth Hormone in Adults With Growth Hormone Deficiency: Overview of 15 809 GH-Treated Patients
• Metabolic Changes across Tertiles of Delta Changes in Height SDS during Growth Hormone Therapy in Children with Growth Hormone Deficiency
• Mutations in GH1 gene and isolated growth hormone deficiency (IGHD): A familial case of IGHD type I and systematic review
• Mutations in the NHEJ component XRCC4 cause primordial dwarfism
• Next-generation sequencing-based mutational analysis of idiopathic short stature and isolated growth hormone deficiency in Korean pediatric patients
• Normal bone density but altered geometry in girls with Turner syndrome
• Novel AICDA mutation in a case of autosomal recessive hyper-IgM syndrome, growth hormone deficiency and autoimmunity
• PEGylated Recombinant Human Growth Hormone Jintrolong^® Exhibits Good Long-Term Safety in Cynomolgus Monkeys and Human Pediatric Growth Hormone Deficiency Patients
• Periodontal disease in adults with untreated congenital growth hormone deficiency: a case-control study
• Persistence with daily growth hormone among children and adolescents with growth hormone deficiency in the UK
• Pharmacokinetics and pharmacodynamics of once-weekly administration of JR-142, a long-acting albumin-fused human growth hormone: A rondemized, placebo-controlled phase 1 study
• Pituitary function and the response to GH therapy in patients with Langerhans cell histiocytosis: analysis of the KIMS database
• Population pharmacokinetic/pharmacodynamic analysis of PEG-rhGH enhances confidence in exploring dosing schemes with longer intervals
• POU1F1/Pou1f1 c.143-83A &gt; G Variant Disrupts the Branch Site in Pre-mRNA and Leads to Dwarfism
• Preliminary study of longitudinal changes in the pituitary and brain of children on growth hormone therapy
• Recombinant growth hormone improves growth and adult height in patients with maternal inactivating GNAS mutations
• Reduced Bone Mineral Density in Middle-Aged Male Patients with Adult Growth Hormone Deficiency
• Relationship Between the Serum FGF21 Level and Growth in Children of Short Stature
• Reply to Letter: Ways to Improve the Diagnosis of Growth Hormone Deficiency
• Response to growth hormone treatment in patients with sufficient secretion
• RESPONSE TO METHOPYRAPONE (SU-4885) AND PYROGEN TEST IN IDIOPATHIC HYPOPITUITARY DWARFISM
• Safety and effectiveness of Omnitrope^® (somatropin) in PATRO Children: a multi-center, post-marketing surveillance study comparison of US and international cohort data
• Safety and Efficacy of Lonapegsomatropin in Children With Growth Hormone Deficiency: enliGHten Trial 2-Year Results
• Safety and Efficacy of Pediatric Growth Hormone Therapy: Results From the Full KIGS Cohort
• Serum IGF-1 to IGFBP-3 Molar Ratio: A Promising Diagnostic Tool for Growth Hormone Deficiency in Children
• Sex steroid priming for growth hormone stimulation testing in children and adolescents with short stature: A systematic review
• Short stature in PRMT7 Mutations: first evidence of response to growth hormone treatment
• Skeletal and dental age discrepancy and occlusal traits in children with growth hormone deficiency and idiopathic short stature
• Skeletal disorders associated with the growth hormone-insulin-like growth factor 1 axis
• Spotlight on Lonapegsomatropin Once-Weekly Injection and Its Potential in the Treatment of Growth Hormone Deficiency in Pediatric Patients
• Switching to Weekly Lonapegsomatropin from Daily Somatropin in Children with Growth Hormone Deficiency: The fliGHt Trial
• Ten year analysis of the clinic profile of the tertiary paediatric endocrine service in Western Australia
• The landscape of retesting in childhood-onset idiopathic growth hormone deficiency and its reversibility: a systematic review and meta-analysis
• The long-term growth, cost-effectiveness, and glycemic effects of growth hormone therapy on children born small for gestational age over 10 years: a retrospective cohort study
• The pharmacokinetic and pharmacodynamic properties and short-term outcome of a novel once-weekly PEGylated recombinant human growth hormone for children with growth hormone deficiency
• The response to growth hormone treatment in a child with short stature, growth hormone deficiency and autosomal dominant cutis laxa type 3 - case report
• The signal transducer and activator of transcription 5B gene polymorphism contributes to the cholesterol metabolism in Japanese children with growth hormone deficiency
• Thyroid function in children with short stature accompanied by isolated pituitary hypoplasia
• Type IA isolated growth hormone deficiency (IGHD) consistent with compound heterozygous deletions of 6.7 and 7.6 Kb at the GH1 gene locus
• Value of diagnostic tests in pituitary dwarfism. 1. Growth hormone deficiency
• Virtual MRI endoscopy of the intracranial cerebrospinal fluid spaces
• Ways to Improve the Diagnosis of Growth Hormone Deficiency
• Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency
• Weekly Somapacitan is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial
• When Is a Positive Test for Pediatric Growth Hormone Deficiency a True-Positive Test?